EDNRA and colorectal cancer: An antagonist of EDNRA, macitentan, has been shown to sensitize colorectal cancer cells [50] and brain metastases [51] to chemotherapy, and it is plausible that it may help to overcome the resistance mechanisms in this TNBC cluster.